Innova Captab Limited has announced key leadership and governance updates following its recent board meeting on May 25, 2026. The board approved the re-appointment of its Managing Director, Whole-Time Director, and four Independent Directors for new five-year terms. Additionally, the company renewed its statutory, cost, and internal audit appointments for the 2026-27 fiscal cycle, as it prepares for its 22nd Annual General Meeting.
Leadership Continuity
The company has secured its leadership structure, re-appointing Mr. Vinay Lohariwala as Managing Director and Mr. Manoj Kumar Lohariwala as Whole-Time Director. Both leaders will serve a second five-year term, effective from March 18, 2027, until March 17, 2032. These appointments underscore the company’s commitment to strategic stability and long-term vision in the pharmaceutical manufacturing and marketing sector.
Strengthening Independent Oversight
In a move to bolster its corporate governance, the board has also re-appointed four Non-Executive Independent Directors for five-year terms: Mr. Sudhir Kumar Bassi, Ms. Priyanka Dixit, Mr. Mahendar Korthiwada, and Mr. Shirish Gundopant Belapure. Their new tenure is set to commence on April 1, 2027, and will run through March 31, 2032.
Audit Renewals and AGM Preparations
Innova Captab has confirmed the renewal of its audit partnerships to ensure financial diligence. M/s. B S R & Co. LLP will continue as the Statutory Auditor for a five-year term covering FY 2026-27 through FY 2030-31. Furthermore, M/s. Gurvinder Chopra and Co. has been retained as the Cost Auditor, and M/s. Grant Thornton Bharat LLP remains the Internal Auditor for the 2026-27 financial year. The company is now formalizing plans for its 22nd Annual General Meeting to finalize these appointments.
Source: BSE
